Elsevier Adds New Functionality to its SciVal Strata Performance Evaluation Tool

Enhanced functionality essential to selecting and assessing a researcher’s most impactful papers

Amsterdam, June 13, 2012 – Elsevier, a world-leading provider of scientific, technical, and medical information products and services, has added a new enhancement to SciVal Strata, a web-based performance evaluation tool that allows users to conduct highly customized performance assessments of research teams and individual researchers. The new functionality provides the capacity for objective assessment of a specific selection of a researcher’s work in addition to their complete publication output. This option is critical when selecting the most impactful papers to be submitted for various government or institutional assessments. In addition the enhanced functionality will prove useful to individuals applying for grants and showing funders the impact of the research they supported.

SciVal Strata is a flexible benchmarking tool providing multi-tier analysis of team and researcher performance such as productivity, citation history, and collaboration activity. The added functionality was developed in global collaboration with users and with Elsevier’s online community of research administrators.

The new functionality to SciVal Strata will help administrators and researchers:

“At Elsevier we are in the business of enhancing the scientific research processes,” said Niels Weertman, Vice President, SciVal, at Elsevier. “Scientific research is about helping to solve some of the world’s most pressing problems; our comprehensive range of resources and tools allow our customers to be more productive and increase the quality and value of their work, rather than spending time on paperwork. The new SciVal Strata functionality will help researchers and administrators fulfill requirements set by the Research Excellence Framework (REF) and other national guidelines. It is part of our mission and commitment to the scientific community to support their vital work.”

# # #

About the Elsevier SciVal Suite
Elsevier’s SciVal® suite of services supports academic and government leadership in evaluating, establishing and executing research strategies that optimize the performance of existing assets and maximize investments to enhance near and long-term productivity. SciVal tools leverage Scopus® data, Elsevier’s trusted source of bibliometric data, to offer innovative yet authoritative solutions. Current suite offerings include: SciVal Spotlight, a strategic tool that generates unique institutional and country maps of existing and emerging research strengths based on an interdisciplinary perspective of current performance; SciVal Funding, an online solution that provides targeted recommendations on grants to pursue based on pre-populated research profiles and historical awards; SciVal Strata, a web-based research performance tool that offers users the flexibility to construct relevant contextual data to evaluate research teams or individual researchers, using a range of indicators based on Scopus data; SciVal Experts, a semantic technology-based application that enables researchers to identify and locate sources of expertise at an individual or departmental level within and across institutions.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Catherine Gold
Elsevier
+1 212 462 1965
c.gold@elsevier.com